BioCentury
ARTICLE | Clinical News

Celgene regulatory update

March 18, 1996 8:00 AM UTC

CELG received European Patent No. 404,146 covering the use of its biocatalysis technology in producing chiral amines. Chiral amines are a class of chemical compounds used in agrichemicals, artificial ...